Annual Financial Report

RNS Number : 8691H

Immupharma PLC

23 May 2014

 

FOR IMMEDIATE RELEASE                                                                             23 May 2014

Annual Report and Accounts

Notice of Annual General Meeting: 27 June 2014

ImmuPharma PLC (AIM:IMM) (the "Company")  the specialist drug discovery and development company, confirms that the Annual Report and Accounts for the year ended 31 December 2013 will be posted to shareholders today.

The Annual Report is available, in electronic form, for download on the Company's website www.immupharma.org.

The Company's Annual General Meeting will be held on Friday 27 June 2014 at 11:00am at the offices of Bircham Dyson Bell LLP, 50 Broadway, London, SW1H 0BL.

For further information please contact:

ImmuPharma PLC

Richard Warr, Chairman                                                [phone]

Dimitri Dimitriou, Chief Executive Officer                     [phone]

Lisa Baderoon, Head of Investor Relations                   [phone]

Panmure Gordon & Co., NOMAD & Broker                    [phone]

Hugh Morgan, Fred Walsh

 

END

 

 

ACSMMGZKVZLGDZM